Resource Center
This section contains international research and may reference indications not approved in all regions. Please consult local approved indications before use.
Filter By:
- News
RAMAT GAN, Israel, Nov. 3, 2025 /PRNewswire/ -- Pulsenmore Ltd. (TASE: PULS), a pioneer in home ultrasound solutions, today announced that the U.S. Food and Drug Administration (FDA) has granted
- News
Innovation happens when clinicians and technology come together.
- News
Stop by the GE HealthCare booth to experience Pulsenmore
- News, Press releases
Pulsenmore (TASE: PULS), a pioneering provider of home-based ultrasound technology, has announced the renewal and expansion of its strategic partnership with Clalit Health Services, Israel's largest HMO. Over the next
- News, Press releases
Pulsenmore secured a commercial agreement with Sheba Medical Center, Tel Hashomer for remote patient monitoring of highrisk pregnancies using its’ home ultrasound solution. Sheba Medical Center, will utilize Pulsenmore's solution
- News, Press releases
Pulsenmore (TASE:PULS), the world leader in self-scan ultrasound technology for at-home use and remote clinical diagnosis, announces its new clinical study collaboration with Michigan Medicine. The study will examine the
the news pulse
We invite you to keep up to date with the latest updates by registering to our quarterly newsletter
FAQ